Ranbaxy, Inc., a subsidiary of India’s Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg), a generic of Pfizer’s Lipitor. The voluntary action is being taken as a precautionary measure due to the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand.   On November 23rd, Ranbaxy posted a notice of the recall on its U.S. website, covering 10 mg, 20 mg and 40 mg ...